NCT01968876 is a EARLY_PHASE1 clinical trial of Medication Adherence Smartphone App in Hypertension, sponsored by University of Arkansas.

Who is sponsoring NCT01968876?

NCT01968876 is sponsored by University of Arkansas.

What drugs are being tested in NCT01968876?

Interventions in NCT01968876: Medication Adherence Smartphone App.

What condition does NCT01968876 study?

NCT01968876 studies Hypertension, Diabetes, Dyslipidemia.

Is NCT01968876 still recruiting?

NCT01968876 is currently terminated. Last updated 20 November 2017.

Last reviewed 2017-11-20 · How we verify

NCT01968876

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Terminated EARLY_PHASE1 Last updated 20 November 2017

What this trial tests

EARLY_PHASE1 trial testing Medication Adherence Smartphone App in Hypertension in 68 participants. Terminated before completion.

Timeline

30 October 2013

Primary endpoint
14 November 2017

14 November 2017

Quick facts

Lead sponsor	University of Arkansas
Phase	EARLY_PHASE1
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	68
Start date	30 October 2013
Primary completion	14 November 2017
Estimated completion	14 November 2017
Sites	3 locations across United States

Drugs / interventions tested

Medication Adherence Smartphone App

Conditions studied

Hypertension — all drugs for Hypertension →
Diabetes — all drugs for Diabetes →
Dyslipidemia — all drugs for Dyslipidemia →

Sponsor

University of Arkansas

Who can join

18 and older, any sex, with Hypertension or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research will act as a pilot study that will be conducted to determine the effectiveness of a smartphone medication adherence application on adherence to oral hypertensive, diabetic, and dyslipidemic medications using a prospective randomized design. Subjects will be recruited from the University of Arkansas for Medical Sciences (UAMS) Internal Medicine Clinic North, and the study data will be collected using only subject self-reports and subject pharmacy records.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other University of Arkansas trials

Trials by the same sponsor.

NCT07029776 — MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma · Phase 2 · not yet recruiting
NCT07341399 — Essential Amino Acid Supplementation in Adult Spinal Deformity Patients · NA · not yet recruiting
NCT07071766 — Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment · NA · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT06604065 — Essential Amino Acids and Parkinsons Disease · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01968876 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Arkansas
Last refreshed: 20 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01968876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing